Skip to main content

Closed

AKBA: Akebia Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

No data

Operating margin2.3%

ROIC2.6%

Financially safe

Stretched

Debt / equity0.46×

Interest coverage0.5×

Current ratio1.40×

Akebia Therapeutics, Inc.

AKBANASDAQ Global Market·USD·Closed

Akebia Therapeutics, Inc.

AKBANASDAQ·USD·Closed

$1.32

−2.22%

$1.32

−$0.03 (2.22%)

52W Range

17thpctl

Volume

0.40×avg

Mkt Cap

354.10MUSD

P/E

-17.5TTM

Div Yield

–ann

52W Range

17thpctl

Volume

0.40×avg

Market Cap

354.10MUSD

P/E Ratio

-17.5TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings